Related Experiment Videos
Proceedings: Hypotensive action of alpha-methyldopamine
British Journal of Pharmacology
|June 1, 1975
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Target Organ Toxicity in Rats After Subchronic Oral Exposure to Soil Extracts Containing a Complex Mixture of Contaminants.
Archives of environmental contamination and toxicology·2022
Genotoxicity of methyl acrylate and ethyl acrylate and its relationship with glutathione.
Archives of toxicology·2022
Necropsy findings of koalas from the Mount Lofty Ranges population in South Australia.
Australian veterinary journal·2018
Acute risk change (ARC) identifies outlier institutions in perioperative cardiac surgical care when the standardized mortality ratio cannot.
British journal of anaesthesia·2016
Findings of the first ANZICS conference on the role of intensive care in Rapid Response Teams.
Anaesthesia and intensive care·2015
Repurposing tirbanibulin as an orally active E2-targeting entry inhibitor against Chikungunya virus.
British journal of pharmacology·2026
Chemoproteomic discovery of a brain-penetrant, covalent NLRP3 inhibitor that binds a novel allosteric pocket.
British journal of pharmacology·2026
Potentiation effects of the positive allosteric modulator PTC-174 on NMDA receptors in neonatal male rat substantia nigra dopaminergic neurons.
British journal of pharmacology·2026
Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm.
British journal of pharmacology·2026
Natural Product Echinocandin Derivative S4286 Induces Mitochondrial Dysfunction to Combat Sclerotinia sclerotiorum.
Journal of agricultural and food chemistry·2026
From SHP2 to DDR1-ERK: A critical signaling axis controlling microglial activation and neuropathic pain after spinal cord injury.
General physiology and biophysics·2026
Association of Cannabis Use With Risk of Subsequent Falls Among Adults Aging With HIV.
Open forum infectious diseases·2026
Bestatin inhibits the development of cutaneous melanoma by inhibiting the expression of LTA4H.
Frontiers in immunology·2026